IGC Pharma, Inc. — Investor Relations & Filings
Filings indexed
762
across all filing types
Latest filing
2026-04-20
Regulatory Filings
Country
US
United States of America
Listing
US
IGC
IGC Pharma, Inc. is a clinical-stage biotechnology company focused on developing treatments for Alzheimer's disease. The company leverages artificial intelligence (AI) in its development process. Its lead candidate, IGC-AD1, is being evaluated in a Phase 2 clinical trial for treating agitation in patients with dementia due to Alzheimer's. The company's pipeline also includes TGR-63, a pre-clinical small molecule designed to inhibit amyloid plaque aggregation. Supporting its therapeutic development is MINT-AD, an AI-powered platform for the early detection of Alzheimer's and to improve the understanding of disease progression.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-04-20 | English | |
| 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-30 | English | |
| 10-KT - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-18 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-01-20 | English | |
| 8-K - IGC PHARMA, INC. (0001326205) (Filer) | 2026-01-06 | English |
Browse filings by year
22 years- 2026 7 filings
- 2025 30 filings
- 2024 37 filings
- 2023 24 filings
- 2022 19 filings
- 2021 31 filings
- 2020 32 filings
- 2019 14 filings
- 2018 43 filings
- 2017 56 filings
- 2016 23 filings
- 2015 26 filings
- 2014 40 filings
- 2013 23 filings
- 2012 48 filings
- 2011 49 filings
- 2010 61 filings
- 2009 49 filings
- 2008 91 filings
- 2007 23 filings
- 2006 26 filings
- 2005 10 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 34693717 | 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-04-20 | English | ||
| 33093350 | 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-30 | English | ||
| 32979091 | 10-KT - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-18 | English | ||
| 28898684 | 4 Filing | 2026-02-04 | English | ||
| 28898699 | 4 Filing | 2026-01-20 | English | ||
| 32890161 | 8-K - IGC PHARMA, INC. (0001326205) (Filer) | 2026-01-06 | English | ||
| 11848719 | FORM 8-K | 2026-01-02 | English | ||
|
2025
8 filings
| |||||
| 11848724 | FORM 8-K | 2025-12-15 | English | ||
| 11848723 | Regulatory Filings 2025 | 2025-12-08 | English | ||
| 11848725 | FORM S-3/A | 2025-12-03 | English | ||
| 11848731 | FORM S-3 | 2025-11-14 | English | ||
| 11848732 | FORM S-8 | 2025-11-14 | English | ||
| 11848730 | FORM 10-Q | 2025-11-14 | English | ||
| 11848726 | FORM 8-K | 2025-11-14 | English | ||
| 11848727 | Director's Dealing 2025 | 2025-10-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Mural Oncology PLC
Clinical-stage biotech developing novel cytokine-based canc…
|
MURA | IE | Professional, scientific and te… |
|
Mydecine Innovations Group Inc.
Developing novel therapeutics using nature-sourced compound…
|
MYCO | CA | Professional, scientific and te… |
|
MYND Life Sciences Inc.
Developing CNS treatments using novel psychedelic and neuro…
|
MYND | CA | Professional, scientific and te… |
|
MyndTec Inc.
Develops neurotechnology products for improving function in…
|
MYTC | CA | Professional, scientific and te… |
|
N4 PHARMA PLC
Develops a silica nanoparticle delivery system for nucleic …
|
N4P | GB | Professional, scientific and te… |
|
NanHua Bio-medicine CO.,Ltd．
Develops cell-based therapies, regenerative medicine, and s…
|
000504 | CN | Professional, scientific and te… |
|
Nanjing Leads Biolabs Co., Ltd.
Clinical-stage biotech discovering and developing innovativ…
|
9887 | HK | Professional, scientific and te… |
|
NanoGroup S.A.
Develops nanotechnology-based medical solutions for oncolog…
|
NNG | PL | Professional, scientific and te… |
|
NANO MRNA Co.,Ltd.
Biotechnology firm creating and out-licensing IP for mRNA-b…
|
4571 | JP | Professional, scientific and te… |
|
NanoSphere Health Sciences Inc.
Nano-biotechnology firm creating advanced drug delivery sys…
|
NSHS | CA | Professional, scientific and te… |
IGC Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34705/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34705 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34705 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34705 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34705}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IGC Pharma, Inc. (id: 34705)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.